Search

Results: 90
Polygenic risk-tailored screening for prostate cancer
BACKGROUND:The United States Preventive Services Task Force supports individualised decision-making for prostate-specific antigen (PSA)-based screening in men aged 55-69. Knowing how the potential benefits and harms of screening...
Published by:
Polygenic risk-tailored screening for prostate cancer
BACKGROUND: The United States Preventive Services Task Force supports individualised decision-making for prostate-specific antigen (PSA)-based screening in men aged 55-69. Knowing how the potential benefits and harms of...
Published by:
Polygenic risk-tailored screening for prostate cancer
Background: The United States Preventive Services Task Force supports individualised decision-making for prostate-specific antigen (PSA)-based screening in men aged 55–69. Knowing how the potential benefits and harms of...
Published by:
Validation of loci at 2q14.2 and 15q21.3 as risk factors for testicular cancer.
Testicular germ cell tumor (TGCT), the most common cancer in men aged 18 to 45 years, has a strong heritable basis. Genome-wide association studies (GWAS) have proposed single nucleotide polymorphisms (SNPs) at a number of loci...
Published by:

|<

<

1

2

3

4

>

>|